Home Drug Codes J Codes J8530 · CYCLOPHOSPHAMIDE
Updated July 1st, 2026

CYCLOPHOSPHAMIDE J Code: J8530

Cyclophosphamide; oral, 25 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J8530, effective October 1, 2026: $1.233 per HCPCS billing unit, down 17.3% from $1.491. From CMS's final file.

?
Medicare Payment Limit ?
$1.491
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
12
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Cyclophosphamide; oral, 25 mg
HCPCS Added Date January 1, 1995
Manufacturer Multiple Manufacturers
Route of Administration Oral
Generic Status Multi-Source; Generic
Dosage Form Capsule | Not Available | Tablet

About CYCLOPHOSPHAMIDE

Cyclophosphamide is a medication aligned to the HCPCS J Code: J8530 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the oral route and manufactured by multiple companies.

According to CMS Drug Use Information: Cyclophosphamide is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cell growth. Cyclophosphamide also works by decreasing your immune system's response to various diseases. It is used to treat a certain type of kidney disease in children after other treatments have not worked.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 12 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00054-0382-25 Cyclophosphamide Hikma Pharmaceuticals USA Inc. 100 25 MG
00054-0383-25 Cyclophosphamide Hikma Pharmaceuticals USA Inc. 200 50 MG
10019-0984-01 Cyclophosphamide Baxter Healthcare Corporation 200 50 MG
69097-0516-07 Cyclophosphamide Cipla USA Inc. 100 25 MG
69097-0517-07 Cyclophosphamide Cipla USA Inc. 200 50 MG
•••••-••••-•• Log in to view CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
Login to view 7 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

CYCLOPHOSPHAMIDE Pricing & Reimbursement

J8530 Private Payer Reimbursement
$1.62 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

CYCLOPHOSPHAMIDE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
96409 Login for More Chemotherapy administration; intravenous, push technique, single or initial substance/drug Login for More
Not on the CMS JW / JZ list

CMS does not include Cyclophosphamide (J8530) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J8530. Wastage billing guide →

CYCLOPHOSPHAMIDE Medically Unlikely Edits (MUE)

The most billing units of J8530 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 25 mg. The limit is different in the office and the hospital. Use the one for your setting.

Practitioner Office
0 units / day
Not payable in this setting
Hospital Outpatient
60 units / day
= 1,500 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

CYCLOPHOSPHAMIDE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Malignant Diseases Minimal Change Nephrotic Syndrome
Drug Class
Alkylating Activity [MoA]Alkylating Drug [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Cyclophosphamide billing and coding guide?
We have not yet identified a manufacturer source of Cyclophosphamide billing and coding information.
Are there any available Cyclophosphamide patient assistance programs?
Our team did not identify a source for Cyclophosphamide patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Cyclophosphamide prescribing information?
CYCLOPHOSPHAMIDE prescribing information can be found at the link below: Visit Here →
Where can I find Cyclophosphamide side effect information?
Information regarding CYCLOPHOSPHAMIDE's side effects can be found at MedlinePlus Visit Here →
Does billing CYCLOPHOSPHAMIDE require JZ/JW wastage modifiers?
CMS does not include CYCLOPHOSPHAMIDE (J8530) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J8530. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.